Literature DB >> 20963406

Dimethyl sulfoxide with lignocaine versus eutectic mixture of local anesthetics: prospective randomized study to compare the efficacy of cutaneous anesthesia in shock wave lithotripsy.

Santosh Kumar1, Sunil Kumar, Raguram Ganesamoni, Arup K Mandal, Seema Prasad, Shrawan K Singh.   

Abstract

The objective of the study was to compare the efficacy of dimethyl sulfoxide (DMSO) mixed with lignocaine and eutectic mixture of local anesthetics (EMLA) cream as topically applied surface anesthetics in relieving pain during shock wave lithotripsy (SWL) in a prospective randomized study. Of the 160 patients, 80 patients received DMSO with lignocaine and 80 patients received EMLA cream, applied to the skin of the flank at the area of entry of shock waves. SWL was done with Seimens lithostar multiline lithotripter. The pain during the procedure was assessed using visual analog and verbal rating scores. The mean visual analog scale scores for the two groups were 3.03 for DMSO group and 4.43 for EMLA group. The difference of pain score on visual analog scale was statistically significant (p < 0.05). Similarly, the pain scores as rated on the verbal rating scale were also evaluated; the mean score on verbal rating scale were 2.34 for DMSO group and 3.00 for the EMLA group. The difference between the pain score on verbal rating scale was also found to be statistically significant (p < 0.05). Our study showed that DMSO with lignocaine is a better local anesthetic agent for SWL than EMLA cream. The stone fragmentation and clearance rates are also better in the DMSO group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963406     DOI: 10.1007/s00240-010-0324-z

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  13 in total

1.  Local anesthesia for extracorporeal shock wave lithotripsy: a study comparing eutetic mixture of local anesthetics cream and lidocaine infiltration.

Authors:  M Honnens de Lichtenberg; J Miskowiak; P Mogensen; J T Andersen
Journal:  J Urol       Date:  1992-01       Impact factor: 7.450

2.  The use of local anesthesia in second generation extracorporeal shock wave lithotripsy: eutectic mixture of local anesthetics.

Authors:  A F Bierkens; R M Maes; J M Hendrikx; A F Erdos; J D de Vries; F M Debruyne
Journal:  J Urol       Date:  1991-08       Impact factor: 7.450

3.  The effects of dimethyl sulfoxide on nerve conduction.

Authors:  W M Sams
Journal:  Ann N Y Acad Sci       Date:  1967-03-15       Impact factor: 5.691

4.  Effect of DMSO on the stabilization of lysosomes by cortisone and chloroquine in vitro.

Authors:  G Weissmann; G Sessa; V Bevans
Journal:  Ann N Y Acad Sci       Date:  1967-03-15       Impact factor: 5.691

5.  Cutaneous anesthesia with lidocaine-prilocaine cream: a useful adjunct during shock wave lithotripsy with analgesic sedation.

Authors:  H G Tiselius
Journal:  J Urol       Date:  1993-01       Impact factor: 7.450

6.  Comparison of the analgesic effects of dimethyl sulfoxide and morphine.

Authors:  H J Haigler; D D Spring
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

7.  The physiological substrate of pain.

Authors:  C N Shealy
Journal:  Headache       Date:  1966-10       Impact factor: 5.887

8.  Use of local anesthesia for extracorporeal shock wave lithotripsy.

Authors:  S Loening; E V Kramolowsky; B Willoughby
Journal:  J Urol       Date:  1987-04       Impact factor: 7.450

9.  Comparing two local anesthesia techniques for extracorporeal shock wave lithotripsy.

Authors:  Erkan Demir; Mete Kilciler; Selahattin Bedir; Koray Erten; Yasar Ozgok
Journal:  Urology       Date:  2007-04       Impact factor: 2.649

10.  Topical anaesthesia for extracorporeal shock wave lithotripsy.

Authors:  P F McDonald; A M Berry
Journal:  Br J Anaesth       Date:  1992-10       Impact factor: 9.166

View more
  1 in total

1.  Dimethyl Sulfoxide Decreases Levels of Oxylipin Diols in Mouse Liver.

Authors:  Poonamjot Deol; Jun Yang; Christophe Morisseau; Bruce D Hammock; Frances M Sladek
Journal:  Front Pharmacol       Date:  2019-05-29       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.